The last few weeks have been historic in the fight against cancer. Novartis got approval for the first treatment in a revolutionary new class of drugs, shortly after Gilead Sciences Inc. spent $11.9 billion on a biotech company working in the field. Neither can rest on its laurels. Research in the field is moving so fast that today’s breakthroughs can easily become tomorrow’s has-beens. “I can’t think of any other therapies in oncology that have seen such rapid development,” said Rachel Webster, senior director of oncology at Decision Resources Group, a health care research and consulting firm in London.
NYS Entity Status
NYS Filing Date
APRIL 16, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - GUERRA CONSULTING GROUP INC.
Around the Web
- Cancer drug research moving fast in immunotherapy field
By Michelle Fay Cortez - Tuesday Sep 5, 2017
- Has ZSC's Samuel Guerra received a contract offer from HC Ambrì-Piotta?
Friday Oct 20, 2017
- Restaurant Review: The Pool Strives to Deal With Its Famous Dining Room
By PETE WELLS - Tuesday Oct 17, 2017
Changes to the landmark interior of the former Four Seasons create challenges for the new restaurant from Major Food Group.
- Anthem Confirms Swedish to Step Down as CEO
Monday Nov 6, 2017
Anthem Inc. has named the former chief executive of UnitedHealth Group Inc.’s insurance business, Gail Boudreaux, its new president and chief executive officer.
- Y&R BAV Group Launches Real-Time Social Media Tool
Tuesday Oct 31, 2017
In an attempt to understand the sprawling online world of content, Y&R's brand consultancy BAV Group is introducing BAVSocial, a new model that combines the group's analytics with filtered socialmedia chatter and engagement.